Oncopeptides AB (publ)
ONPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$283,498 | -$253,447 | -$349,350 | -$1,420,917 |
| Dep. & Amort. | $0 | $11,040 | $17,161 | $14,994 |
| Deferred Tax | $0 | $0 | -$19,146 | $34,198 |
| Stock-Based Comp. | $0 | $0 | $19,146 | -$34,198 |
| Change in WC | -$2,679 | -$55,967 | -$109,233 | -$38,082 |
| Other Non-Cash | $25,607 | $18,881 | $20,913 | -$72,386 |
| Operating Cash Flow | -$260,570 | -$279,493 | -$420,509 | -$1,516,391 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$116 | -$2,507 | -$339 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$1 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $496 | $1 | $0 | $0 |
| Investing Cash Flow | $496 | -$116 | -$2,507 | -$339 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8,029 | $116,024 | $0 | $0 |
| Stock Issued | $313,483 | $0 | $435,611 | $1,116,488 |
| Stock Repurch. | $0 | -$24 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$41,640 | -$9,135 | -$43,209 | -$82,458 |
| Financing Cash Flow | $263,814 | $106,889 | $392,402 | $1,034,030 |
| Forex Effect | $1,389 | $1,613 | $12,942 | $4,633 |
| Net Chg. in Cash | $5,130 | -$171,108 | -$17,672 | -$478,068 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $173,406 | $344,515 | $362,187 | $840,255 |
| End Cash | $178,536 | $173,407 | $344,515 | $362,187 |
| Free Cash Flow | -$260,570 | -$279,609 | -$423,016 | -$1,516,730 |